Clinical Trial Update: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study of BI-2536 in patients with recurrent or metastatic solid tumors, including breast cancer, endometrial cancer, head and neck cancer, melanoma, ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Head and Neck Cancer
• Melanoma
• Ovarian Cancer
• Sarcoma

Drugs mentioned

• BI-2536

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED